These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27136969)

  • 1. Structural insight into selective phosphodiesterase 4B inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sharma V; Wakode S
    J Biomol Struct Dyn; 2017 May; 35(6):1339-1349. PubMed ID: 27136969
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure based virtual screening to identify selective phosphodiesterase 4B inhibitors.
    Gangwal RP; Damre MV; Das NR; Dhoke GV; Bhadauriya A; Varikoti RA; Sharma SS; Sangamwar AT
    J Mol Graph Model; 2015 Apr; 57():89-98. PubMed ID: 25687765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay.
    Li Z; Cai YH; Cheng YK; Lu X; Shao YX; Li X; Liu M; Liu P; Luo HB
    J Chem Inf Model; 2013 Apr; 53(4):972-81. PubMed ID: 23517293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors.
    Tripuraneni NS; Azam MA
    J Theor Biol; 2016 Apr; 394():117-126. PubMed ID: 26804643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discover natural compounds as potential phosphodiesterase-4B inhibitors via computational approaches.
    Li J; Zhou N; Liu W; Li J; Feng Y; Wang X; Wu C; Bao J
    J Biomol Struct Dyn; 2016 May; 34(5):1101-12. PubMed ID: 26159554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Novel Phosphodiesterase-2A Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay.
    Zhang C; Feng LJ; Huang Y; Wu D; Li Z; Zhou Q; Wu Y; Luo HB
    J Chem Inf Model; 2017 Feb; 57(2):355-364. PubMed ID: 28055196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling, docking studies and molecular dynamic simulations using graphical processing unit architecture to probe the type-11 phosphodiesterase catalytic site: a computational approach for the rational design of selective inhibitors.
    Cichero E; D'Ursi P; Moscatelli M; Bruno O; Orro A; Rotolo C; Milanesi L; Fossa P
    Chem Biol Drug Des; 2013 Dec; 82(6):718-31. PubMed ID: 23865680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
    Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
    J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds.
    Li Z; Lu X; Feng LJ; Gu Y; Li X; Wu Y; Luo HB
    Mol Biosyst; 2015 Jan; 11(1):115-25. PubMed ID: 25328054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure-activity relationships.
    Zhou ZZ; Ge BC; Chen YF; Shi XD; Yang XM; Xu JP
    Bioorg Med Chem; 2015 Nov; 23(22):7332-9. PubMed ID: 26526739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors.
    Plummer MS; Cornicelli J; Roark H; Skalitzky DJ; Stankovic CJ; Bove S; Pandit J; Goodman A; Hicks J; Shahripour A; Beidler D; Lu XK; Sanchez B; Whitehead C; Sarver R; Braden T; Gowan R; Shen XQ; Welch K; Ogden A; Sadagopan N; Baum H; Miller H; Banotai C; Spessard C; Lightle S
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3438-42. PubMed ID: 23582272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SAR.
    Mitchell CJ; Ballantine SP; Coe DM; Cook CM; Delves CJ; Dowle MD; Edlin CD; Hamblin JN; Holman S; Johnson MR; Jones PS; Keeling SE; Kranz M; Lindvall M; Lucas FS; Neu M; Solanke YE; Somers DO; Trivedi NA; Wiseman JO
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5803-6. PubMed ID: 20732811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, and molecular modeling of new 3-(cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitors.
    Brullo C; Massa M; Rocca M; Rotolo C; Guariento S; Rivera D; Ricciarelli R; Fedele E; Fossa P; Bruno O
    J Med Chem; 2014 Aug; 57(16):7061-72. PubMed ID: 25126889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water Pharmacophore: Designing Ligands using Molecular Dynamics Simulations with Water.
    Jung SW; Kim M; Ramsey S; Kurtzman T; Cho AE
    Sci Rep; 2018 Jul; 8(1):10400. PubMed ID: 29991756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.
    Singh N; Tiwari S; Srivastava KK; Siddiqi MI
    J Chem Inf Model; 2015 Jun; 55(6):1120-9. PubMed ID: 25965448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.
    Tian S; Sun H; Li Y; Pan P; Li D; Hou T
    J Chem Inf Model; 2013 Oct; 53(10):2743-56. PubMed ID: 24010823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing protein-ligand binding modes with computational tools: the case of PDE4B.
    Çifci G; Aviyente V; Akten ED; Monard G
    J Comput Aided Mol Des; 2017 Jun; 31(6):563-575. PubMed ID: 28534194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.